rs72773422

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001038603.3(MARVELD2):​c.898T>A​(p.Leu300Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00197 in 1,614,208 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L300L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 6 hom. )

Consequence

MARVELD2
NM_001038603.3 missense

Scores

2
2
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:4

Conservation

PhyloP100: 0.0900

Publications

6 publications found
Variant links:
Genes affected
MARVELD2 (HGNC:26401): (MARVEL domain containing 2) The protein encoded by this gene is a membrane protein found at the tight junctions between epithelial cells. The encoded protein helps establish epithelial barriers such as those in the organ of Corti, where these barriers are required for normal hearing. Defects in this gene are a cause of deafness autosomal recessive type 49 (DFNB49). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
MARVELD2 Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 49
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010410309).
BP6
Variant 5-69420283-T-A is Benign according to our data. Variant chr5-69420283-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 178409.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00161 (245/152314) while in subpopulation NFE AF = 0.00294 (200/68034). AF 95% confidence interval is 0.00261. There are 1 homozygotes in GnomAd4. There are 105 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MARVELD2NM_001038603.3 linkc.898T>A p.Leu300Met missense_variant Exon 2 of 7 ENST00000325631.10 NP_001033692.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MARVELD2ENST00000325631.10 linkc.898T>A p.Leu300Met missense_variant Exon 2 of 7 1 NM_001038603.3 ENSP00000323264.5

Frequencies

GnomAD3 genomes
AF:
0.00161
AC:
245
AN:
152196
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000459
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00207
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00294
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00167
AC:
420
AN:
251494
AF XY:
0.00157
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.000954
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00273
Gnomad NFE exome
AF:
0.00259
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00201
AC:
2943
AN:
1461894
Hom.:
6
Cov.:
35
AF XY:
0.00199
AC XY:
1448
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33480
American (AMR)
AF:
0.000894
AC:
40
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000765
AC:
2
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000371
AC:
32
AN:
86258
European-Finnish (FIN)
AF:
0.00256
AC:
137
AN:
53420
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.00230
AC:
2560
AN:
1112012
Other (OTH)
AF:
0.00270
AC:
163
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
207
414
620
827
1034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00161
AC:
245
AN:
152314
Hom.:
1
Cov.:
32
AF XY:
0.00141
AC XY:
105
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41578
American (AMR)
AF:
0.000458
AC:
7
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00207
AC:
22
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00294
AC:
200
AN:
68034
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
15
29
44
58
73
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00257
Hom.:
1
Bravo
AF:
0.00124
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00209
AC:
18
ExAC
AF:
0.00181
AC:
220
Asia WGS
AF:
0.000577
AC:
3
AN:
3478
EpiCase
AF:
0.00229
EpiControl
AF:
0.00213

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:3
Nov 12, 2018
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 30, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 26, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25885414)

Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MARVELD2: BP4

Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive nonsyndromic hearing loss 49 Uncertain:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

May 23, 2017
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Jan 26, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Leu300Met in exon 2 of MARVELD2: This variant is not expected to have clinical significance because it has been identified in 0.3% (178/67708) of European chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs72773422). In addition, 3 species (chicken, duck, and lizard) have a methionine (Met) at this position despite high nearby amino acid conservation, supporting that this change may be tolerated.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0
.;T;T;T;.;T
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.40
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.0
.;.;.;T;T;T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.010
T;T;T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.3
L;L;L;L;L;.
PhyloP100
0.090
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
0.0
.;N;.;.;N;N
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;T;.;.;T;T
Sift4G
Pathogenic
0.0
.;T;.;.;T;T
Vest4
0.0
ClinPred
0.023
T
GERP RS
0.18
Varity_R
0.073
gMVP
0.82
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72773422; hg19: chr5-68716110; COSMIC: COSV57782616; COSMIC: COSV57782616; API